Pipeline & Product

Pipeline & Product

Development Candidate (Indication)

Pre-Clinical

Phase 1

Phase 2

Phase 3

Status/Next Steps

LPCN 1154

Postpartum depression

Phase 3
Topline results early Q2/26

LPCN 2203

Essential Tremor

P1 study completed

LPCN 1148

Liver Cirrhosis

P2 study completed

LPCN 1107

Prevention of preterm birth

End of Phase 2 meeting completed

Product

Pre-Clinical

Phase 1

Phase 2/POC

Pivotal

Approved

Status/Next Steps

TLANDO

TRT

Marketed

Innovating beyond
boundaries for patients